| Financial Year |
March 31 2023 |
| Monetary Funds |
343,797,345.29 |
| Held-for-trading Financial Assets |
270,611,633.68 |
| Notes Receivable |
-- |
| Accounts Receivable |
128,746,084.25 |
| Advances to Suppliers |
19,991,627.98 |
| Other Receivables |
8,041,282.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
105,451,429.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,496,478.12 |
| Total Current Assets |
882,135,881.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,696,606.08 |
| Investment Properties |
-- |
| Fixed Assetes |
250,820,285.61 |
| Under-construction Projects |
4,060,844.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
77,026,203.77 |
| R&D expenses |
-- |
| Goodwill |
17,594,506.89 |
| Long-Term Deferred and Prepaid Expenses |
7,802,058.80 |
| Deferred Income Tax Assets |
17,203,330.30 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
567,849,325.65 |
| Total Assets |
1,449,985,207.05 |
| Short-Term Loans |
132,986,825.84 |
| Trading Financial liabilities |
-- |
| Notes Payable |
107,559,945.32 |
| Accounts Payable |
91,737,527.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,513,493.58 |
| Taxes Payable |
1,939,273.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,920,903.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,680,603.75 |
| Other Current Liabilities |
1,178,088.50 |
| Sub-Total of Current Liabilities |
419,449,687.58 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,292,800.00 |
| Deferred Income Tax Liabilities |
26,887,955.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
45,738,556.22 |
| Total Liabilities |
465,188,243.80 |
| Paid-In Capital(Or Share Stock) |
214,701,188.00 |
| Capital Surplus |
505,584,392.29 |
| Surplus Reserve |
42,374,025.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
191,355,118.08 |
| Minority Stockholder's Interest |
-13,521,061.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
998,318,025.21 |
| Owner's Equity（Stockholder's Equity） |
984,796,963.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,449,985,207.05 |
